bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.
Open | $1.340 |
Close | $1.280 |
Volume / Avg. | 7.270M / 9.959M |
Day Range | 1.250 - 1.420 |
52 Wk Range | 0.879 - 5.530 |
Market Cap | $246.710M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 15.84% |
Days to Cover | 3.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of bluebird bio (NASDAQ: BLUE) through any online brokerage.
Other companies in bluebird bio’s space includes: FibroGen (NASDAQ:FGEN), Gritstone Bio (NASDAQ:GRTS), Century Therapeutics (NASDAQ:IPSC), Black Diamond Therapeutic (NASDAQ:BDTX) and 2seventy bio (NASDAQ:TSVT).
The latest price target for bluebird bio (NASDAQ: BLUE) was reported by RBC Capital on Wednesday, March 27, 2024. The analyst firm set a price target for 6.00 expecting BLUE to rise to within 12 months (a possible 368.75% upside). 19 analyst firms have reported ratings in the last year.
The stock price for bluebird bio (NASDAQ: BLUE) is $1.28 last updated March 28, 2024 at 7:52 PM EDT.
There are no upcoming dividends for bluebird bio.
bluebird bio’s Q4 earnings are confirmed for Friday, March 3, 2023.
There is no upcoming split for bluebird bio.
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.